Click here for full price details of
GYKI 52466 hydrochloride
Chemical Name:4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-y
l)-benzenamine hydrochloride
Biological Activity:
Selective non-competitive AMPA receptor
antagonist (IC50 values are 10-20, ~ 450 and >> 50 μM for AMPA- ,
kainate- and NMDA-induced responses respectively). Skeletal muscle relaxant and
orally-active anticonvulsant. Has anti-proliferative effects in transformed
cells.
Tarnawaet al
(1989) Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant:
GYKI 52466. Eur.J.Pharmacol. 167 193. Donevan and Rogawski
(1993) GYKI 52466, a 2,3-benzodiazepine, is a highly selective, non-competitive
antagonist of AMPA/kainate receptor responses. Neuron 10 51.Paternainet al (1995) Selective
antagonism of AMPA receptors unmasks kainate receptor-mediated responses in
hippocampal neurons. Neuron 14 185.Rzeskiet al (2001) Glutamate antagonists limit tumor growth.
Proc.Natl.Acad.Sci.USA 98 6372. Szabadoset al
(2001) Comparison of anticonvulsive and acute neuroprotective activity of three
2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain
Res.Bull. 55 387.
Displays 26-fold and > 440-fold selectivity over kainate and NMDA receptors respectively. Neuro-protective; delays neuronal death in a global ischaemia model and cerebral infarction in a focal ischaemia model.